Business
Dr. Agnes Olszewski, CEO of Herborium Group, speaks about Herborium’s unique global opportunities for Botanical Therapeutics® in an interview with Prominent Wealth & Finance International
Dr. Agnes Olszewski, CEO of Herborium Group, speaks about Herborium’s unique global opportunities for Botanical Therapeutics® in an interview with Prominent Wealth & Finance International.
About this update from Herborium Group, Inc.
[{"type":"text","content":"Fort Lee, N.J. January 30, 2017 - Herborium® Group, Inc. (OTC Pink: HBRM), a Botanical Therapeutics® Company providing unique, all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne as well as other health and wellness concerns, announced today that its CEO, Dr. Agnes P. Olszewski, was interviewed by Prominent Wealth & Finance International. The full interview can be read at http://www.wealthandfinance-intl.com/wealth---finance-january-2017 and http://www.wealthandfinance-intl.com/\nWealth & Finance International is highly recognized publication targeting an established global network of high net worth individuals, forward-thinking fund managers and private and institutional investors, hungry for the latest news and opinion on the issues that matter most. \nWith a global audience of over 130,000, our engaged and established readership stretches from North America (51%) and Europe and UK (38%) to Asia and the Middle East. In addition Wealth and Finance is also available on ISSUU platform with over 100 Million Unique Visitors per month.\nDr. Agnes talked about the new landscape of the nutraceutical market and the opportunities and challenges of natural medicine and wellness. She points out how Herborium’s proprietary Botanical Therapeutics®, its innovative business model and its unique blend of expertise has positioned the company in the bull’s eye of this aggressively growing sector. \nThe global nutraceutical market is currently valued at about USD $250 billion in 2016 and is expected to reach ~ USD $385 billion by the year 2021. The United States nutraceutical market has dominated this growth, accounting for approximately 36% of this growth. \nHerborium’s sales results for the first three quarters of 2016 grew by 14% in comparison to the same period of 2015, and the fourth quarter results beat expectations and grew 16.8% in comparison to the same period of 2015 \nHerborium’s Botanical Therapeutics are systemic, proprietary, all herbal products that contain no chemicals, gluten, or GMOs and have been scientifically validated with respect to their efficacy and safety. They address unsatisfied market needs such as Acne and Rosacea ($5 billion), Male Sexual Health ($8 billion), Women’s Sexual Health ($6 billion) and energy re...